1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 11,200 | 11,300 | 21.05. | |
| 11,200 | 11,400 | 21.05. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.05. | Mizuho raises Fortrea stock price target to $13 on EBITDA boost | 1 | Investing.com | ||
| 06.05. | BofA raises Fortrea stock price target on improved revenue trends | 4 | Investing.com | ||
| 05.05. | Fortrea reiterates 2026 revenue of $2.55B-$2.65B amid $190M-$220M adjusted EBITDA target | 2 | Seeking Alpha | ||
| 05.05. | Fortrea Holdings Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| FORTREA Aktie jetzt für 0€ handeln | |||||
| 05.05. | Evercore ISI raises Fortrea stock price target on execution improvements | 2 | Investing.com | ||
| 05.05. | Fortrea Q1 2026: Marge steigt dank Kostensenkungen um 270 Basispunkte | 3 | Investing.com Deutsch | ||
| 05.05. | Fortrea Holdings Inc: Fortrea Reports First Quarter 2026 Results | 240 | GlobeNewswire (Europe) | Strong first-quarter performance reinforces confidence in FY 2026 guidanceBook-to-bill of 1.15x is third consecutive quarter above 1.1x Highlights For the three months ended March 31, 2026: Revenues... ► Artikel lesen | |
| 05.05. | Fortrea Holdings Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.04. | Evercore Adjusts Fortrea Holdings Inc. (FTRE) Valuation Following Updated Near-Term Assumptions | 3 | Insider Monkey | ||
| 08.04. | Fortrea Holdings Inc: Fortrea stellt "Fortrea Intelligent Technology" vor, um Sponsoren und Studienzentren dabei zu unterstützen, klinische Studien intelligenter und integrierter durchzuführen | 951 | GlobeNewswire (Deutschland) | Die KI-gestützte Lösungssuite bietet neue und verbesserte Technologien, die für mehr Effizienz, Zuverlässigkeit und Qualität sorgenHighlights:
Entwickelt, um die Abläufe bei klinischen Studien für... ► Artikel lesen | |
| 07.04. | Fortrea stellt KI-gestützte Technologie-Suite für klinische Studien vor | 4 | Investing.com Deutsch | ||
| 07.04. | Fortrea unveils AI-powered clinical trial technology suite | 2 | Investing.com | ||
| 07.04. | Fortrea Holdings Inc: Fortrea Unveils Fortrea Intelligent Technology to Help Sponsors and Sites Run Smarter, More Integrated Trials | 365 | GlobeNewswire (Europe) | AI-enhanced suite of solutions features new and improved technology to empower efficiency, confidence and qualityHighlights:
Designed to transform clinical trial operations for sponsors, sites and... ► Artikel lesen | |
| 10.03. | Fortrea Holdings Inc: Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| 09.03. | TD Cowen upgrades Fortrea stock rating on improving bookings | 1 | Investing.com | ||
| 05.03. | Mizuho cuts Fortrea stock price target to $13 on lower estimates | 2 | Investing.com | ||
| 27.02. | Deep Dive Into Fortrea Holdings Stock: Analyst Perspectives (7 Ratings) | 3 | Benzinga.com | ||
| 26.02. | Fortrea Holdings Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 26.02. | Fortrea targets $2.55B-$2.65B revenue for 2026 as margin improvement efforts intensify | 2 | Seeking Alpha | ||
| 26.02. | Fortrea Q4 2025 slides: revenue dips, transformation advances amid headwinds | 2 | Investing.com |
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BB BIOTECH | 47,800 | -0,31 % | Aktien KW 17 Märkte im Würgegriff. Planloser Trump , selbstbewusterer Iran. Lösungen müssen her. News. Rheinmetall. ITM Power. Porsche. The Platform Group. K+S. Bugatti. Circus. Surteco. NanoRepro. BB Biotech. Mensch und Maschine. ATOSS. MHP Hotel | Aktien - letzte Woche warteten die Märkte auf eine Lösung des Iran-Kriegs. Aber die Iraner sehen sich im Vorteil und Trump verlängert "auf unbestimmte Zeit" den Waffenstillstand. Aber die Strasse von... ► Artikel lesen | |
| QIAGEN | 30,095 | +0,62 % | QIAGEN N.V.: QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA | Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights' curated biomedical knowledge bases Goal to advance how disease mechanisms... ► Artikel lesen | |
| AMGEN | 290,00 | -0,14 % | Dividendenbekanntmachungen (15.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,06 USD 0,0514 EUR AF GRUPPEN ASA NO0003078107 6,5 NOK 0,6029 EUR AGCO CORPORATION US0010841023 0... ► Artikel lesen | |
| NOVAVAX | 7,760 | +0,39 % | Novavax, Inc.: Novavax Reports First Quarter 2026 Financial Results and Operational Highlights | Total revenue of $140 million in the first quarter of 2026
Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M® in two infectious... ► Artikel lesen | |
| STRYKER | 270,00 | +0,07 % | Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business | WASHINGTON (dpa-AFX) - Tuesday, BioStar Capital announced that Amplitude Vascular Systems, Inc., a medical technology company, has been acquired by Stryker Corporation (SYK) at a purchase price... ► Artikel lesen | |
| ILLUMINA | 123,84 | -0,63 % | Illumina adds former Labcorp CEO to board of directors | ||
| CRISPR THERAPEUTICS | 42,910 | -0,08 % | CRISPR Therapeutics AG: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results | ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. "The first quarter reflected... ► Artikel lesen | |
| AAP IMPLANTATE | 2,000 | +0,50 % | EQS-HV: aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.06.2026 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: aap Implantate AG
/ Bekanntmachung der Einberufung zur Hauptversammlung
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.06.2026 in Berlin... ► Artikel lesen | |
| OCUGEN | 1,184 | +2,25 % | Ocugen Provides Business Update with First Quarter 2026 Financial Results | Conference Call and Webcast Today at 8:30 a.m. ET Positive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial for geographic atrophy (GA) indicates a statistically significant (p About 20%... ► Artikel lesen | |
| INTELLIA THERAPEUTICS | 10,640 | -0,19 % | Can Intellia's Pipeline Push Drive Long-Term Growth Amid Rivalry? | ||
| TEMPUS AI | 39,900 | -0,31 % | How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here | ||
| SCORPIUS | - | - | Antares Global launches Scorpius MGA platform under Ian Morris | ||
| DEFENCE THERAPEUTICS | 0,289 | +1,40 % | Defence Therapeutics Inc.: Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | Montreal, Quebec--(Newsfile Corp. - May 19, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular... ► Artikel lesen | |
| EDITAS MEDICINE | 2,320 | +0,87 % | Editas Medicine, Inc.: Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting | CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, shared new preclinical... ► Artikel lesen | |
| BIOCRYST PHARMACEUTICALS | 7,370 | +2,39 % | BioCryst Ireland, a Neopharmed Gentili company: Hereditary angioedema, a European initiative to shine a spotlight on a still under-recognized condition | Ahead of World HAE Day, BioCryst Ireland, a Neopharmed Gentili company, organised an international event in Milan bringing together leading experts from across Europe to raise awareness of... ► Artikel lesen |
FORTREA HOLDINGS INC gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 11,100 Euro und damit -0,89 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FORTREA HOLDINGS INC finden Sie auf Wallstreet Online.